Replimune prices USD 150 million follow-on stock offering at USD 12.06 per share
REPL•Follow-on offering priced at USD 12.06 per share
Replimune priced an underwritten follow-on offering expected to raise about USD 150 million in gross proceeds.
- The deal includes 9,701,490 common shares at USD 12.06 each.
- It also includes pre-funded warrants for 2,736,340 shares at USD 12.0599 each, with a USD 0.0001 exercise price.
- The offering is expected to close on Aug. 11, 2026, subject to customary conditions.
- Leerink Partners, J.P. Morgan, and Cantor are bookrunning managers.
